KICK-OFF HARMONi
In the following 3 years, Biosfer Teslab will be coordinating a consortium of companies and research centers in the framework of the project HARMONi. HARnessing the power of MultiOmics: Towards the generation of Novel & Innovative diagnostic tools to improve cardiovascular risk prediction. This project will be funded under the call for Projects in public-private […]
Metabolomics and Sexual Reproductive Health
The Marató de TV3 has announced that the upcoming edition, scheduled for December 17, 2023, will focus on Sexual and Reproductive Health (SSIR), a crucial theme impacting millions in Catalonia and globally. In this context, exploring innovative approaches in research is imperative, and metabolomics emerges as a promising tool to advance our understanding and treatment […]
What does metabolomics contribute to HIV research?
Nuclear Magnetic Resonance (NMR) metabolomics emerges as a promising tool in HIV research due to its ability to provide a detailed insight into molecular changes in the body. By studying metabolomic profiles in individuals affected by HIV, NMR enables the identification of specific metabolic alterations associated with the infection. This approach not only facilitates the […]
Biosfer Teslab joins the charity run ‘Lliga’t a la Vida’
In an effort to contribute to the fight against cancer, Biosfer Teslab has actively participated in ‘Lliga’t a la Vida’. An exciting charity run that aims to raise funds and bring visibility to this devastating disease. ‘Lliga’t a la Vida-Trail’ was born with the enthusiasm of merging a love for sports with solidarity. In collaboration […]
Glycoproteins: Emerging Markers of Inflammation
Cardiovascular events occur despite the control of conventional risk factors. Inflammation plays numerous roles in the pathogenesis of atherosclerotic cardiovascular disease. As an alternative to traditional inflammatory markers, new biomarkers of systemic inflammation, including Glyc-A and Glyc-B measured by nuclear magnetic resonance (NMR), have been explored. Especially, the concentration of Glyc-A has been associated as […]
What is metabolomics and how is it applied in diabetes?
Metabolomic profiling involves identifying intermediary molecules and end-products of metabolism, encompassing lipids, lipoproteins, fatty acid variants, amino acids, and glycoprotein acetyls. This approach holds promise for discovering novel biomarkers indicative of disease risk and offers fresh perspectives on molecular mechanisms, biological processes, and implicated disease pathways. Diabetes, affecting over 500 million people in 2021, stands […]
Biosfer Teslab at the event “Empowering the Future We Want”
On Monday, October 16, 2023, our CEO Núria Amigó participated in the event “Empowering the Future We Want” alongside Jose Bayon Lopez, CEO of ENISA, and Juan Merodio. The purpose of this event was to introduce the #SpainUpNation program. ENISA, the National Innovation Company, is a public entity under the Ministry of Industry, Commerce, and […]
Discordance between LDL-C levels and LDL particle number
Lipoproteins are much more than just vehicles for cholesterol in our body. Although lipid analysis has traditionally focused on measuring levels of total, HDL, and LDL cholesterol, science has advanced, and we now know that lipoproteins play a much more complex role in our cardiovascular health. Not only do they carry cholesterol, but they also […]
Cardiovascular Disease: Beyond LDL Cholesterol
Cardiovascular disease (CVD) claims the lives of over 4 million people in Europe every year. Dyslipidemia, a disorder characterized by abnormal blood lipid levels, is one of the most significant risk factors for the development of CVD. Specifically, LDL cholesterol plays a central role in the relationship between cardiovascular disease and dyslipidemia. However, a high […]
How NMR metabolomics & artificial intelligence revolutionize neonatal health, clinical decision-making and diagnosis
NMR metabolomics & AI in neonatal health Did you know that there are almost 3 million fetal and neonatal deaths every year? Did you know that Fetal growth restriction (FGR) is the largest contributor to stillbirth – the death or loss of a baby before or during delivery?. FGR is associated with neonatal morbidity and mortality, and […]
